From August 2021, Dr. Diane Langenbacher starts as a partner. She brings strategic strengths and extensive business experience from 25 years of health advocacy on the pharmaceutical company side in the national and international environment.

For Kautz5 gUG, Ms. Langenbacher will be involved in patient-centric health services research as well as health policy communication and strategic development on a project-by-project basis and thus complements the expertise of Kautz5 gUG.